Christopher M. Kramer

38.5k total citations · 12 hit papers
368 papers, 19.6k citations indexed

About

Christopher M. Kramer is a scholar working on Radiology, Nuclear Medicine and Imaging, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Christopher M. Kramer has authored 368 papers receiving a total of 19.6k indexed citations (citations by other indexed papers that have themselves been cited), including 226 papers in Radiology, Nuclear Medicine and Imaging, 219 papers in Cardiology and Cardiovascular Medicine and 90 papers in Surgery. Recurrent topics in Christopher M. Kramer's work include Cardiac Imaging and Diagnostics (201 papers), Advanced MRI Techniques and Applications (146 papers) and Cardiovascular Function and Risk Factors (97 papers). Christopher M. Kramer is often cited by papers focused on Cardiac Imaging and Diagnostics (201 papers), Advanced MRI Techniques and Applications (146 papers) and Cardiovascular Function and Risk Factors (97 papers). Christopher M. Kramer collaborates with scholars based in United States, United Kingdom and Germany. Christopher M. Kramer's co-authors include Michael Salerno, Scott D. Flamm, Eike Nagel, Raymond J. Kim, Frederick H. Epstein, Matthias G. Friedrich, Jörg Barkhausen, Jeanette Schulz‐Menger, Walter J. Rogers and David A. Bluemke and has published in prestigious journals such as New England Journal of Medicine, Circulation and Nature Medicine.

In The Last Decade

Christopher M. Kramer

351 papers receiving 19.2k citations

Hit Papers

Cardiovascular Magnetic Resonance in ... 2008 2026 2014 2020 2018 2013 2009 2020 2010 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation
    2018 1.2k citations Christopher M. Kramer et al. Journal of the American College of Cardiology profile →
  2. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing
    2013 1.2k citations Christopher M. Kramer et al. profile →
  3. Criteria for Evaluation of Novel Markers of Cardiovascular Risk
    2009 806 citations Mark A. Hlatky, Philip Greenland et al. Circulation profile →
  4. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update
    2020 647 citations Christopher M. Kramer et al. profile →
  5. ACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance
    2010 578 citations W. Gregory Hundley, Christopher M. Kramer et al. Circulation profile →
  6. Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update
    2020 574 citations Christopher M. Kramer et al. profile →
  7. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update
    2013 532 citations Christopher M. Kramer et al. profile →
  8. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols
    2008 529 citations Christopher M. Kramer et al. profile →
  9. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 Multimodality Appropriate Use Criteria for the Detection and Risk Assessment of Stable Ischemic Heart Disease
    2013 383 citations Christopher M. Kramer et al. Journal of the American College of Cardiology profile →
  10. Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
    2024 284 citations Milton Packer, Michael R. Zile et al. profile →
  11. Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure
    2024 63 citations Christopher M. Kramer, Barry A. Borlaug et al. Journal of the American College of Cardiology profile →
  12. Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial
    2024 46 citations Barry A. Borlaug, Michael R. Zile et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher M. Kramer United States 67 12.9k 10.0k 4.1k 2.4k 1.7k 368 19.6k
Michael Jerosch‐Herold United States 67 8.8k 0.7× 7.9k 0.8× 2.2k 0.5× 1.4k 0.6× 1.4k 0.8× 297 14.2k
Jeanette Schulz‐Menger Germany 55 11.8k 0.9× 8.4k 0.8× 2.4k 0.6× 1.5k 0.6× 799 0.5× 286 16.0k
Matthias G. Friedrich Canada 56 13.5k 1.0× 10.3k 1.0× 3.3k 0.8× 1.2k 0.5× 898 0.5× 353 18.9k
Sven Plein United Kingdom 59 10.1k 0.8× 10.8k 1.1× 3.0k 0.7× 1.6k 0.7× 1.6k 0.9× 497 16.3k
Albert C. van Rossum Netherlands 64 9.9k 0.8× 8.2k 0.8× 3.4k 0.8× 1.4k 0.6× 1.3k 0.8× 484 14.9k
Andrew E. Arai United States 71 9.1k 0.7× 10.6k 1.1× 2.3k 0.6× 1.4k 0.6× 1.7k 1.0× 307 16.6k
Ernst E. van der Wall Netherlands 85 20.0k 1.6× 10.5k 1.0× 6.6k 1.6× 3.5k 1.5× 2.7k 1.5× 678 27.3k
Paolo G. Camici Italy 78 15.2k 1.2× 11.1k 1.1× 6.1k 1.5× 1.6k 0.7× 1.2k 0.7× 347 22.3k
Eike Nagel Germany 68 12.5k 1.0× 14.3k 1.4× 3.8k 0.9× 1.9k 0.8× 2.5k 1.4× 431 21.2k
Warren J. Manning United States 89 17.0k 1.3× 14.4k 1.4× 4.4k 1.1× 3.4k 1.4× 1.7k 1.0× 485 28.4k

Countries citing papers authored by Christopher M. Kramer

Since Specialization
Citations

This map shows the geographic impact of Christopher M. Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Kramer more than expected).

Fields of papers citing papers by Christopher M. Kramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Kramer. The network helps show where Christopher M. Kramer may publish in the future.

Co-authorship network of co-authors of Christopher M. Kramer

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher M. Kramer. A scholar is included among the top collaborators of Christopher M. Kramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher M. Kramer. Christopher M. Kramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Borlaug, Barry A., Michael R. Zile, Christopher M. Kramer, et al.. (2024). Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial. Nature Medicine. 31(2). 544–551. 46 indexed citations breakdown →
2.
Pan, Jonathan A., A Löffler, Yang Yang, et al.. (2024). Cardiometabolic biomarker patterns associated with cardiac MRI defined fibrosis and microvascular dysfunction in patients with heart failure with preserved ejection fraction. Frontiers in Cardiovascular Medicine. 11. 1334226–1334226. 3 indexed citations
3.
Wang, Shuo, Angela M. Taylor, Todd C. Villines, et al.. (2024). Emerging Pathway to a Precision Medicine Approach for Angina With Nonobstructive Coronary Arteries in Women. SHILAP Revista de lepidopterología. 3(8). 101074–101074. 3 indexed citations
4.
Kramer, Christopher M., Barry A. Borlaug, Dustin Ruff, et al.. (2024). Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure. Journal of the American College of Cardiology. 85(7). 699–706. 63 indexed citations breakdown →
5.
Kramer, Christopher M., et al.. (2024). Impact of an institutional process change adopting end-systolic coronary CTA acquisition and automated dose selection on patient throughput and image quality. Journal of cardiovascular computed tomography. 19(1). 113–120.
6.
Dong, Tiffany, et al.. (2023). Multimodality imaging of hypertrophic cardiomyopathy. Progress in Cardiovascular Diseases. 80. 14–24. 7 indexed citations
7.
Huang, Qiao, Brandon A. Kemp, Nancy L. Howell, et al.. (2023). Progressive Cardiac Metabolic Defects Accompany Diastolic and Severe Systolic Dysfunction in Spontaneously Hypertensive Rat Hearts. Journal of the American Heart Association. 12(10). e026950–e026950. 1 indexed citations
8.
Berry, Colin, Christopher M. Kramer, Vijay Kunadian, et al.. (2023). Great Debate: Computed tomography coronary angiography should be the initial diagnostic test in suspected angina. European Heart Journal. 44(26). 2366–2375. 4 indexed citations
9.
Blanc‐Durand, Félix, Christopher M. Kramer, Etienne Rouleau, et al.. (2023). 788P Molecular profiling of p53 mutant endometrial cancer reveals distinct subgroups with opportunities for personalized therapeutic approaches. Annals of Oncology. 34. S529–S530.
10.
Kramer, Christopher M., et al.. (2023). Magnetic Resonance Imaging Techniques in Peripheral Arterial Disease. Advances in Wound Care. 12(11). 611–625. 2 indexed citations
11.
Bunse, Lukas, et al.. (2022). Clinical and Translational Advances in Glioma Immunotherapy. Neurotherapeutics. 19(6). 1799–1817. 24 indexed citations
12.
Robinson, Austin, Feifei Zhao, Paige Miller, et al.. (2021). Abstract 14111: Feasibility of Therapeutic Ultrasound Delivery for the Treatment of Mitral Stenosis. Circulation. 144(Suppl_1).
13.
Waring, Adam, Andrew R. Harper, Silvia Salatino, et al.. (2020). Data-driven modelling of mutational hotspots and in silico predictors in hypertrophic cardiomyopathy. Journal of Medical Genetics. 58(8). 556–564. 3 indexed citations
14.
Li, Jie, Nancy L. Howell, Rahul Roy, et al.. (2020). Metformin Improves Cardiac Metabolism and Function, and Prevents Left Ventricular Hypertrophy in Spontaneously Hypertensive Rats. Journal of the American Heart Association. 9(7). e015154–e015154. 20 indexed citations
15.
Hamirani, Yasmin S., et al.. (2016). Anthracycline- and trastuzumab-induced cardiotoxicity: a retrospective study. Medical Oncology. 33(7). 82–82. 30 indexed citations
16.
Kramer, Christopher M., et al.. (2012). Lastprognose für energieeffiziente verteilte DBMS.. GI-Jahrestagung. 397–411. 1 indexed citations
17.
Kramer, Christopher M., W. Gregory Hundley, & Eugene Braunwald. (2010). Atlas of cardiovascular magnetic resonance imaging : imaging companion to Braunwald's Heart disease. Saunders eBooks. 3 indexed citations
18.
Hlatky, Mark A., Philip Greenland, Donna K. Arnett, et al.. (2009). Criteria for Evaluation of Novel Markers of Cardiovascular Risk. Circulation. 119(17). 2408–2416. 806 indexed citations breakdown →
19.
Kramer, Christopher M., Matthew J. Budoff, Zahi A. Fayad, et al.. (2007). ACCF/AHA 2007 Clinical Competence Statement on Vascular Imaging With Computed Tomography and Magnetic Resonance. Circulation. 116(11). 1318–1335. 16 indexed citations
20.
Kramer, Christopher M., Matthew J. Budoff, Zahi A. Fayad, et al.. (2007). ACCF/AHA 2007 Clinical Competence Statement on Vascular Imaging With Computed Tomography and Magnetic Resonance. Journal of the American College of Cardiology. 50(11). 1097–1114. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Jerosch‐Herold Breakdown of academic impact, for papers by Jeanette Schulz‐Menger Breakdown of academic impact, for papers by Matthias G. Friedrich Breakdown of academic impact, for papers by Sven Plein Breakdown of academic impact, for papers by Albert C. van Rossum Breakdown of academic impact, for papers by Andrew E. Arai Breakdown of academic impact, for papers by Ernst E. van der Wall Breakdown of academic impact, for papers by Paolo G. Camici Breakdown of academic impact, for papers by Eike Nagel Breakdown of academic impact, for papers by Warren J. Manning
Rankless by CCL
2026